MedTrace Logo

Supplementary Oxygen in Surgical and Medical Wards Evaluated by 30-day Mortality

NCT03625700 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11196

Last updated 2021-01-12

No results posted yet for this study

Summary

This study evaluates the use and effects of supplementary oxygen in surgical and medical wards on patients admitted to a hospital in the capital region of Denmark. The population will be divided in to three groups according to their oxygenation status. The main outcome will be 30-day mortality, with secondary outcomes being Length of stay, 30-day admission to ICU, 30-day reoperations, 30-day readmission, and peak values within 30-days of C-reactive protein, S-Creatinine, Troponin.

Conditions

  • Oxygen Toxicity
  • Oxygen Deficiency

Interventions

DRUG

Oxygen gas

Supplementary oxygen supplied via nasal catheter or oxygen mask during hospital admission.

Sponsors & Collaborators

  • Hannibal Troensegaard

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2020-08-31
Completion
2020-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03625700 on ClinicalTrials.gov